Loading…
Loading…
MCK · NYSE · Healthcare
“At 26 times earnings, McKesson's valuation appears stretched relative to its pharmaceutical distribution fundamentals, offering little margin of safety for the prudent investor.”
— In the voice of Graham
Year-to-date total return including price appreciation. Compare performance against the S&P 500 benchmark.
Market Cap
$113.60B
P/E Ratio
26.17
Forward P/E
—
EPS
$9.63
PEG Ratio
0.69
Book Value
$-10.54
Dividend Yield
0.09%
Profit Margin
1.12%
ROE
—
Use the interactive ytd return with pre-loaded data for Mckesson Corporation. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for MCK: